Michigan Gov. Gretchen Whitmer, a potential 2028 candidate, wants to find common ground with Trump
Biden promised to turn the page on Trump. Now he's being replaced by him
Firefighters prepare for increasing gusts following brief reprieve for LA area
Nippon Steel wants to work with Trump administration on US Steel deal, Mori tells WSJ
After cable damage, Taiwan to step up surveillance of flag of convenience ships
BOJ will raise rates if economy, price conditions continue to improve, Ueda says
Manatees congregate in warm waters near power plants as US winter storms graze Florida
AAPI adults prioritize immigration, but split on mass deportations: AP-NORC/AAPI Data poll
As Los Angeles burns, Hollywood's Oscar season turns into a pledge drive
As fires ravage Los Angeles, Tiger Woods isn't sure what will happen with Riviera tournament
Antetokounmpo gets 50th career triple-double as Bucks win 130-115 to end Kings' 7-game win streak
MADRID (Reuters) - United States-based buyout fund KKR is in exclusive talks with Germany' Fresenius to buy Eugin, fertility clinics in Spain and Portugal, Spanish newspaper Cinco Dias reported on Monday citing unidentified financial sources.
A potential deal would value Eugin at around 500 million euros ($528.55 million), the newspaper said.
KKR would buy the clinics with a Spanish partner, it added.
The U.S. fund already owns assets in the industry in the country, Cinco Dias reported.
KKR, Fresenius and Eugin did not immediately respond to messages seeking comment.
($1 = 0.9460 euros)
(Reporting by Inti Landauro, Editing by Louise Heavens)
